These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3114651)
21. P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens. Driessen B; von Kügelgen I; Starke K Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):42-8. PubMed ID: 7935853 [TBL] [Abstract][Full Text] [Related]
22. Desensitization of alpha(2)-adrenoceptors which regulate noradrenaline synthesis and release after chronic treatment with clorgyline in the rat brain. Prieto M; Giralt MT Pharmacology; 2002 May; 65(1):49-56. PubMed ID: 11901301 [TBL] [Abstract][Full Text] [Related]
23. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat. Harsing LG; Vizi ES J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730 [TBL] [Abstract][Full Text] [Related]
24. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl. Hársing LG; Vizi ES Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273 [TBL] [Abstract][Full Text] [Related]
25. Effect of selective monoamine oxidase A and B inhibitors on footshock induced aggression in paired rats. Datla KP; Bhattacharya SK Indian J Exp Biol; 1990 Aug; 28(8):742-5. PubMed ID: 2123820 [TBL] [Abstract][Full Text] [Related]
26. Influence of thyroid status on responses of rat isolated pulmonary artery, vas deferens and trachea to smooth muscle relaxant drugs. O'Donnell SR; Wanstall JC; Mustafa MB Br J Pharmacol; 1987 Sep; 92(1):221-9. PubMed ID: 3664088 [TBL] [Abstract][Full Text] [Related]
27. Effect of the dihydropyridine Bay K 8644 on the release of [3H]-noradrenaline from the rat isolated vas deferens. Ceña V; García AG; Khoyi MA; Salaices M; Sanchez-García P Br J Pharmacol; 1985 Jul; 85(3):691-6. PubMed ID: 2411327 [TBL] [Abstract][Full Text] [Related]
28. Evidence that ATP released from the postsynaptic site by noradrenaline, is involved in mechanical responses of guinea-pig vas deferens: cascade transmission. Vizi ES; Sperlágh B; Baranyi M Neuroscience; 1992 Sep; 50(2):455-65. PubMed ID: 1331864 [TBL] [Abstract][Full Text] [Related]
29. Effect of blockade of noradrenaline re-uptake on evoked tritium overflow from mouse vasa deferentia and rat cortex slices. el-Mas M; Hughes IE Br J Pharmacol; 1990 Nov; 101(3):762-8. PubMed ID: 2076491 [TBL] [Abstract][Full Text] [Related]
30. The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations. Lai JC; Leung TK; Guest JF; Lim L; Davison AN Biochem Pharmacol; 1980 Oct; 29(20):2763-7. PubMed ID: 6776961 [No Abstract] [Full Text] [Related]
31. 3H-noradrenaline release from rat neocortical slices in the absence of extracellular Ca2+ and its presynaptic alpha 2-adrenergic modulation. A study on the possible role of cyclic AMP. Schoffelmeer AN; Mulder AH Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):188-92. PubMed ID: 6312334 [TBL] [Abstract][Full Text] [Related]
32. Sympathomimetic activity of mazindol on rat anococcygeus muscle and vas deferens. Zarrindast MR Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):258-63. PubMed ID: 6712359 [TBL] [Abstract][Full Text] [Related]
33. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors. Gudelsky GA; Koenig JI; Jackman H; Meltzer HY Psychopharmacology (Berl); 1986; 90(3):403-7. PubMed ID: 2947256 [TBL] [Abstract][Full Text] [Related]
34. In vivo degradation of noradrenaline by MAO A in locus coeruleus of the rat. Blinc M; Dernovsek M; Sket D Experientia; 1989 Dec; 45(11-12):1099-102. PubMed ID: 2513220 [TBL] [Abstract][Full Text] [Related]
35. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain. Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528 [TBL] [Abstract][Full Text] [Related]
36. Inhibition by the putative potassium channel opener pinacidil of the electrically-evoked release of endogenous dopamine and noradrenaline in the rat vas deferens. Soares-da-Silva P; Fernandes MH Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):415-21. PubMed ID: 2255335 [TBL] [Abstract][Full Text] [Related]
37. Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog. Caramona MM; Araújo D; Brandão F Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):401-6. PubMed ID: 3921856 [TBL] [Abstract][Full Text] [Related]
38. Errors introduced by a tritium label in position 8 of catecholamines. Grohmann M; Henseling M; Cassis L; Trendelenburg U Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):34-42. PubMed ID: 2419773 [TBL] [Abstract][Full Text] [Related]
39. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat. Rényi L Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms of the release of 3H-noradrenaline by dimethylphenylpiperazinium (DMPP) in the rat vas deferens. Niebler M; Trendelenburg U Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):43-9. PubMed ID: 2314482 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]